Small Caps “Anatara Lifesciences secures Zoetis catalyst for its novel Detach product”

15 MAY 2018 SMALL CAPS
GEORGE TCHETVERTAKOV

Anatara Lifesciences secures Zoetis catalyst for its novel Detach product

Biotechnology company Anatara Lifesciences (ASX: ANR) has teamed up with animal health developer Zoetis Inc. to develop, manufacture and distribute its Detach product.

The news is significant given that Zoetis has over 60 years’ experience in the sector and currently derives almost two thirds of its US$5.3 billion annual revenue from farm animal health products.

The exclusive licensing agreement will also include marketing of Detach, as a non-antibiotic approach to aid in the control of diarrhoeal disease – otherwise known as ‘scour’ – in livestock and horses.

To read the full article please click here: https://smallcaps.com.au/anatara-lifesciences-zoetis-catalyst-detach-product/